key: cord-0811274-65wmm1wi
authors: Turba, M. E.; Mion, D.; Papadimitriou, S.; Taddei, F.; Dirani, G.; Sambri, V.; Gentilini, F.
title: Affordable and time-effective high throughput screening of SARS-CoV-2 variants using Denaturing High-Performance Liquid Chromatography analysis
date: 2021-04-29
journal: nan
DOI: 10.1101/2021.04.27.21256156
sha: 12b45b4136a15d2810c17a480bcb8e18dcba443f
doc_id: 811274
cord_uid: 65wmm1wi

Mutations in the receptor binding domain region of SARS-CoV-2 have been shown to impact the infectivity, pathogenicity and transmissibility of new variants. Even more worrisome, those mutations have the potential of causing immune escape, undermining the population immunity induced by ongoing mass vaccination programs. The massive parallel sequencing techniques have taken a lead role in the detection strategies of the new variants. Nevertheless, they are still cumbersome and labour-demanding. As a matter of fact, there is an urgent need for novel strategies and techniques aimed at the surveillance of the active emergence and spread of the variants of concern. Two PCRs were designed to target the binding domain region, spanning residues N417 through N501 of the Spike protein. Furthermore, very rapid, affordable and straightforward Denaturing High-Performance Liquid Chromatography screening was set up. The screening consisted of mixing the unknown sample with a standard sample of a known sequence, denaturing at high temperature for two minutes, renaturing for 15 minutes followed by a 2-minute run using the WAVE DHPLC system to detect the heteroduplexes which invariably originate whenever the unknown sample has a nucleotide difference with respect to the standard used. The workflow was able to readily detect new variants including the P.1 and the B.1.585 strains at a very affordable cost. This approach has the potential of greatly expediting surveillance of the SARS-CoV-2 variants.

The SARS-CoV-2 genome is relatively stable due to the proofreading activity operated by a 3'-to-5' exoribonuclease (nsp14-ExoN) during replication which reduces the error rate of RNA polymerase 100-1000-fold as compared with other RNA viruses. This confers the capacity of maintaining its 30,000 nt genome to the virus without catastrophic mutational events hampering its integrity Triggle et al., 2021] . Nonetheless, errors still occur in the SARS-CoV-2 genome at a higher rate than eukaryotic cells and, together with high replication rates, allow for the accumulation of mutations in the viral genome including amino acid changes, truncations or the loss of viral proteins . Whenever these changes impact infectivity, pathogenicity and transmissibility, As the COVID-19 pandemic continues, and vaccination programs expand, however, a novel factor of positive selection has taken place represented by the rapid rise of acquired immunity in the population [Jung, 2021] . As the majority of vaccines exploit the immunogenicity of the Spike protein, due to its pivotal role in binding to the ACE2 cell receptor and entry into the host cell, the strict monitoring of mutations in the domains targeted by the neutralising antibodies should be implemented worldwide [Focosi and Maggi, 2021; Gomez et al., 2021; Dobey et al., 2021. In particular, substitutions in the receptor binding domain (RBD) have emerged, and they are of particular concern due to the possibility of being responsible for immune escape. More specifically, the B. In fact, some of the variants of concern which might escape vaccine immunity are being monitored.

To this end, an unprecedented sequencing effort has been pushed forward by the implementation of next generation sequencing (NGS) programmes. However, NGS is still cumbersome and very labour intensive. As a consequence, the approach to sequencing any viral genome is still unaffordable and, likely, unwise. Alternatives have been proposed to be integrated with sequencing in order to more effectively monitor the variants of concern [Bal et al., Banada et al., 2021] .

The aim of this study was to provide a very quick, cheap straightforward method; this aim was achieved using Denaturing High-Performance Liquid Chromatography (DHPLC) to screen the RBD of SARS-CoV-2 isolates.

Positive samples diagnosed with Covid-19 by means of diagnostic reverse transcription polymerase chain reaction (RT-PCR) (Seegene) underwent DHPLC screening and entire genome sequencing using Oxford Nanopore. Furthermore, some samples from External Quality Assessment (EQA) for Molecular Diagnostics were also included in this proof-of-concept study. All the samples were retrotranscribed using an iScript cDNA Synthesis Kit (Bio-Rad). The overall workflow of the screening proposed is represented in Figure 1 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The optimal oven temperatures for heteroduplex separation were determined using Navigator™ Software (ADS Biotec) which gave a computer-assisted determination of the melting profile and analytical conditions for each fragment which were then experimentally verified. A partially denaturing temperature of 55.5°C was then used for the DHPLC screening of the N417T/N mutation in RBD_1 amplicon and a partially denaturing temperature of 56.6° C for the E484K and N501Y mutations in the RBD_2 amplicon. The data analysis was carried out using Navigator™ Software (ADS Biotec). Following the DHPLC screening, the same amplicons were purified and sequenced using an ABI310 automated sequencer (ThermoFisher). All the variants used in the study had already . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 29, 2021. ; https://doi.org/10.1101/2021.04.27.21256156 doi: medRxiv preprint been fully sequenced using a modified Artic protocol (unpublished) involving Nanopore Sequencing (Oxford Nanopore Technologies).

When two amplicons containing nucleotide variations are denatured by heating and left to renature by cooling, in addition to homoduplexes, heteroduplexes due to cross-hybridisation between the mismatched strands are also formed; DHPLC exploits the different retention times of homoduplexes and heteroduplexes in order to detect their multiple retention peaks. To almost cover the entire RBD of the Spike protein, two PCRs were designed, and the respective amplicons were screened for mutations using DHPLC. A sample of a known sequence was used as a standard and was mixed with unknown samples. Whenever more than one retention peak was evident at DHPLC, it indicated that a mismatch, and hence a mutation, existed between the standard and the sample.

The setup of the assays was straightforward. To obtain sharp and easily interpretable peaks at DHPLC analysis, PCR reactions should avoid the formation of nonspecific amplicons and smears. The highfidelity Phusion Taq polymerase is well-suited for this purpose; furthermore, the PCR reactions using Phusion Taq are very rapid in reducing the PCR step. It should also be pointed out that the Phusion buffer does not contain any detergent which would be detrimental for downstream DHPLC analysis.

In this study involving DHPLC analysis, the B.1 strain isolated in March 2020 carrying the K417, E484 and N501 residues in the RBD_1 and RBD_2 amplicons was first used. Using this strain, the prevalent Y501 [Kirby, 2021] could be identified ( Figure 2 ) and used as a standard for subsequent analysis which allowed detecting the P.1 and B1.585 variants (Figure 3) , as confirmed by Sanger Sequencing of the amplicons and whole genome sequencing using Oxford Nanopore (Oxford Nanopore Technologies).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 29, 2021. ; https://doi.org/10.1101/2021.04.27.21256156 doi: medRxiv preprint Overall, the process was able to be completed in a few hours. Potentially, all new positives would be able to be screened on the same day of diagnosis using a dedicated thermal cycler and the WAVE® DHPLC system (Figure 1 ). Besides the cost of the additional PCR reaction, an additional reagent cost for each DHPLC analysis would be 1.40 Euros/amplicon. This amounts to 2.80 Euros/sample when considering both RBD_1 and RBD_2 targets.

The Spike protein has different hotspots of mutation and deletion; the most likely candidates for immune escape are those within the RBD, such as K417N/T, E484K, and N501Y; N439K, L452R, Alarmingly, a convergent evolution has led to diverse groupings of those mutations among different clades [Focosi and Maggi, 2021] . Using known sequenced strains, DHPLC is able to rapidly screen a large number of samples, establishing whether they share the same combination of mutations in the RBD or eventually not. In the latter case, additional combinations may be rapidly ascertained in a few minutes by mixing and denaturing at high temperature, allowing renaturing and running in DHPLC is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) There are no patents products in development or marketed products to declare. All authors are committed to adhere to the Journal policies on sharing data and materials.

Partial financial support was received from AUSL Romagna under the protocol code "COVdPCR"

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of AUSL Romagna under the protocol code "COVdPCR of 07/02/2020. (include appropriate approvals or waivers)

Not applicable. Informed Consent Statement: The samples included in this study were sent to the Unit of Micro-biology, Greater Romagna Area Hub Laboratory, Cesena, Italy, for routine diagnostic purposes and the laboratory data results were reported as answer to a clinical suspicion.

As such, informed consent from patients was not required. Each sample included was preventively anonymized.

Some viral strain included in the study had been investigated within the interlaboratory "INSTAND e.V." external proficiency testing program.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 29, 2021. ; https://doi.org/10.1101/2021.04.27.21256156 doi: medRxiv preprint

Spike mutation D614G alters SARS-CoV-2 fitness

Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19. Vaccines (Basel)

Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines

The variant gambit: COVID-19's next move

The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design

Functional importance of the D614G mutation in the SARS-CoV-2 spike protein

The Impact of Mutations in SARS

CoV-2 Spike on Viral Infectivity and Antigenicity. Cell

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring

Evolution patterns of SARS-CoV-2: Snapshot on its genome variants

New variant of SARS-CoV-2 in UK causes surge of COVID-19

Preparing for the Coronavirus Disease (COVID-19) Vaccination: Evidence, Plans, and Implications

Oxford-AstraZeneca COVID-19 vaccine efficacy

Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection

Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic. Front Immunol

Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination

CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted

SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Simple RT-PCR Melting temperature Assay to Rapidly Screen for Widely Circulating SARS-CoV-2

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

The copyright holder for this preprint this version posted April 29, 2021. ; https://doi.org/10.1101/2021.04.27.21256156 doi: medRxiv preprint Figure 1 : Workflow for the rapid screening of the variants of concern.. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 29, 2021. ; https://doi.org/10.1101/2021.04.27.21256156 doi: medRxiv preprint Figure 3 : Selected example of the detection of rare variants of concern using the Denaturing High-Performance Liquid Chromatography system. Using the B.1.1.7 strain as a standard, the rarer B.1.585 (Nigerian) and P.1. (Brazilian) variants could be detected and confirmed.. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 29, 2021. ; https://doi.org/10.1101/2021.04.27.21256156 doi: medRxiv preprint